-
1
-
-
84881489108
-
Insights into the molecular mechanisms underlying mammalian P2X7 receptor functions and contributions in diseases, revealed by structural modeling and single nucleotide polymorphisms
-
L.H. Jiang, J.M. Baldwin, S. Roger, and S.A. Baldwin Insights into the molecular mechanisms underlying mammalian P2X7 receptor functions and contributions in diseases, revealed by structural modeling and single nucleotide polymorphisms Front Pharmacol 4 2013 55
-
(2013)
Front Pharmacol
, vol.4
, pp. 55
-
-
Jiang, L.H.1
Baldwin, J.M.2
Roger, S.3
Baldwin, S.A.4
-
2
-
-
84875426837
-
P2X receptors as drug targets
-
R.A. North, and M.F. Jarvis P2X receptors as drug targets Mol Pharmacol 83 4 2013 759 769
-
(2013)
Mol Pharmacol
, vol.83
, Issue.4
, pp. 759-769
-
-
North, R.A.1
Jarvis, M.F.2
-
3
-
-
84869045095
-
P2X7 receptors: Channels, pores and more
-
C. Volonte, S. Apolloni, S.D. Skaper, and G. Burnstock P2X7 receptors: channels, pores and more CNS Neurol Disord Drug Targets 11 6 2012 705 721
-
(2012)
CNS Neurol Disord Drug Targets
, vol.11
, Issue.6
, pp. 705-721
-
-
Volonte, C.1
Apolloni, S.2
Skaper, S.D.3
Burnstock, G.4
-
4
-
-
57249111810
-
Activation of P2X7 receptors induces CCL3 production in microglial cells through transcription factor NFAT
-
A. Kataoka, H. Tozaki-Saitoh, Y. Koga, M. Tsuda, and K. Inoue Activation of P2X7 receptors induces CCL3 production in microglial cells through transcription factor NFAT J Neurochem 108 1 2009 115 125
-
(2009)
J Neurochem
, vol.108
, Issue.1
, pp. 115-125
-
-
Kataoka, A.1
Tozaki-Saitoh, H.2
Koga, Y.3
Tsuda, M.4
Inoue, K.5
-
5
-
-
0035884937
-
P2X7-like receptor activation in astrocytes increases chemokine monocyte chemoattractant protein-1 expression via mitogen-activated protein kinase
-
W. Panenka, H. Jijon, L.M. Herx, J.N. Armstrong, D. Feighan, and T. Wei et al. P2X7-like receptor activation in astrocytes increases chemokine monocyte chemoattractant protein-1 expression via mitogen-activated protein kinase J Neurosci 21 18 2001 7135 7142
-
(2001)
J Neurosci
, vol.21
, Issue.18
, pp. 7135-7142
-
-
Panenka, W.1
Jijon, H.2
Herx, L.M.3
Armstrong, J.N.4
Feighan, D.5
Wei, T.6
-
6
-
-
77954325416
-
P2X7 receptor activation induces CXCL2 production in microglia through NFAT and PKC/MAPK pathways
-
M. Shiratori, H. Tozaki-Saitoh, M. Yoshitake, M. Tsuda, and K. Inoue P2X7 receptor activation induces CXCL2 production in microglia through NFAT and PKC/MAPK pathways J Neurochem 114 3 2010 810 819
-
(2010)
J Neurochem
, vol.114
, Issue.3
, pp. 810-819
-
-
Shiratori, M.1
Tozaki-Saitoh, H.2
Yoshitake, M.3
Tsuda, M.4
Inoue, K.5
-
7
-
-
78349245841
-
Cathepsin S release from primary cultured microglia is regulated by the P2X7 receptor
-
A.K. Clark, R. Wodarski, F. Guida, O. Sasso, and M. Malcangio Cathepsin S release from primary cultured microglia is regulated by the P2X7 receptor Glia 58 14 2010 1710 1726
-
(2010)
Glia
, vol.58
, Issue.14
, pp. 1710-1726
-
-
Clark, A.K.1
Wodarski, R.2
Guida, F.3
Sasso, O.4
Malcangio, M.5
-
8
-
-
77956936562
-
P2X(7) receptor-mediated release of cathepsins from macrophages is a cytokine-independent mechanism potentially involved in joint diseases
-
G. Lopez-Castejon, J. Theaker, P. Pelegrin, A.D. Clifton, M. Braddock, and A. Surprenant P2X(7) receptor-mediated release of cathepsins from macrophages is a cytokine-independent mechanism potentially involved in joint diseases J Immunol 185 4 2010 2611 2619
-
(2010)
J Immunol
, vol.185
, Issue.4
, pp. 2611-2619
-
-
Lopez-Castejon, G.1
Theaker, J.2
Pelegrin, P.3
Clifton, A.D.4
Braddock, M.5
Surprenant, A.6
-
9
-
-
33645981958
-
P2X(7) receptors exert a permissive role on the activation of release-enhancing presynaptic alpha7 nicotinic receptors co-existing on rat neocortex glutamatergic terminals
-
L. Patti, L. Raiteri, M. Grilli, M. Parodi, M. Raiteri, and M. Marchi P2X(7) receptors exert a permissive role on the activation of release-enhancing presynaptic alpha7 nicotinic receptors co-existing on rat neocortex glutamatergic terminals Neuropharmacology 50 6 2006 705 713
-
(2006)
Neuropharmacology
, vol.50
, Issue.6
, pp. 705-713
-
-
Patti, L.1
Raiteri, L.2
Grilli, M.3
Parodi, M.4
Raiteri, M.5
Marchi, M.6
-
10
-
-
84875589081
-
The role of glutamate release mediated by extrasynaptic P2X7 receptors in animal models of neuropathic pain
-
R.D. Ando, and B. Sperlagh The role of glutamate release mediated by extrasynaptic P2X7 receptors in animal models of neuropathic pain Brain Res Bull 93 2013 80 85
-
(2013)
Brain Res Bull
, vol.93
, pp. 80-85
-
-
Ando, R.D.1
Sperlagh, B.2
-
11
-
-
0035983598
-
Involvement of P2X7 receptors in the regulation of neurotransmitter release in the rat hippocampus
-
B. Sperlagh, A. Kofalvi, J. Deuchars, L. Atkinson, C.J. Milligan, and N.J. Buckley et al. Involvement of P2X7 receptors in the regulation of neurotransmitter release in the rat hippocampus J Neurochem 81 6 2002 1196 1211
-
(2002)
J Neurochem
, vol.81
, Issue.6
, pp. 1196-1211
-
-
Sperlagh, B.1
Kofalvi, A.2
Deuchars, J.3
Atkinson, L.4
Milligan, C.J.5
Buckley, N.J.6
-
12
-
-
0035883160
-
Neuronal P2X7 receptors are targeted to presynaptic terminals in the central and peripheral nervous systems
-
S.A. Deuchars, L. Atkinson, R.E. Brooke, H. Musa, C.J. Milligan, and T.F. Batten et al. Neuronal P2X7 receptors are targeted to presynaptic terminals in the central and peripheral nervous systems J Neurosci 21 18 2001 7143 7152
-
(2001)
J Neurosci
, vol.21
, Issue.18
, pp. 7143-7152
-
-
Deuchars, S.A.1
Atkinson, L.2
Brooke, R.E.3
Musa, H.4
Milligan, C.J.5
Batten, T.F.6
-
13
-
-
84874614647
-
ATP induces NO production in hippocampal neurons by P2X(7) receptor activation independent of glutamate signaling
-
J.F. Codocedo, J.A. Godoy, M.I. Poblete, N.C. Inestrosa, and J.P. Huidobro-Toro ATP induces NO production in hippocampal neurons by P2X(7) receptor activation independent of glutamate signaling PLoS One 8 3 2013 e57626
-
(2013)
PLoS One
, vol.8
, Issue.3
, pp. 57626
-
-
Codocedo, J.F.1
Godoy, J.A.2
Poblete, M.I.3
Inestrosa, N.C.4
Huidobro-Toro, J.P.5
-
14
-
-
84878124765
-
The inflammasome: Pathways linking psychological stress, depression, and systemic illnesses
-
M. Iwata, K.T. Ota, and R.S. Duman The inflammasome: pathways linking psychological stress, depression, and systemic illnesses Brain Behav Immun 31 2013 105 114
-
(2013)
Brain Behav Immun
, vol.31
, pp. 105-114
-
-
Iwata, M.1
Ota, K.T.2
Duman, R.S.3
-
15
-
-
77957268367
-
Microglia: Proliferation and activation driven by the P2X7 receptor
-
M. Monif, G. Burnstock, and D.A. Williams Microglia: proliferation and activation driven by the P2X7 receptor Int J Biochem Cell Biol 42 11 2010 1753 1756
-
(2010)
Int J Biochem Cell Biol
, vol.42
, Issue.11
, pp. 1753-1756
-
-
Monif, M.1
Burnstock, G.2
Williams, D.A.3
-
16
-
-
34247868178
-
Modulation of the purinergic P2X7 receptor attenuates lipopolysaccharide-mediated microglial activation and neuronal damage in inflamed brain
-
H.B. Choi, J.K. Ryu, S.U. Kim, and J.G. McLarnon Modulation of the purinergic P2X7 receptor attenuates lipopolysaccharide-mediated microglial activation and neuronal damage in inflamed brain J Neurosci 27 18 2007 4957 4968
-
(2007)
J Neurosci
, vol.27
, Issue.18
, pp. 4957-4968
-
-
Choi, H.B.1
Ryu, J.K.2
Kim, S.U.3
McLarnon, J.G.4
-
17
-
-
33947647866
-
Purinergic modulation of microglial cell activation
-
B. Sperlagh, and P. Illes Purinergic modulation of microglial cell activation Purinergic Signal 3 1-2 2007 117 127
-
(2007)
Purinergic Signal
, vol.3
, Issue.12
, pp. 117-127
-
-
Sperlagh, B.1
Illes, P.2
-
19
-
-
59549102347
-
Inhibition of the ATP-gated P2X7 receptor promotes axonal growth and branching in cultured hippocampal neurons
-
M. Diaz-Hernandez, A. Del Puerto, J.I. Diaz-Hernandez, M. Diez-Zaera, J.J. Lucas, and J.J. Garrido et al. Inhibition of the ATP-gated P2X7 receptor promotes axonal growth and branching in cultured hippocampal neurons J Cell Sci 121 Pt. 22 2008 3717 3728
-
(2008)
J Cell Sci
, vol.121
, Issue.PART. 22
, pp. 3717-3728
-
-
Diaz-Hernandez, M.1
Del Puerto, A.2
Diaz-Hernandez, J.I.3
Diez-Zaera, M.4
Lucas, J.J.5
Garrido, J.J.6
-
20
-
-
0034531974
-
ATP: An extracellular signaling molecule between neurons and glia
-
R.D. Fields, and B. Stevens ATP: an extracellular signaling molecule between neurons and glia Trends Neurosci 23 12 2000 625 633
-
(2000)
Trends Neurosci
, vol.23
, Issue.12
, pp. 625-633
-
-
Fields, R.D.1
Stevens, B.2
-
21
-
-
76149099290
-
The P2X7 purinergic receptor: From physiology to neurological disorders
-
S.D. Skaper, P. Debetto, and P. Giusti The P2X7 purinergic receptor: from physiology to neurological disorders FASEB J 24 2 2009 337 345
-
(2009)
FASEB J
, vol.24
, Issue.2
, pp. 337-345
-
-
Skaper, S.D.1
Debetto, P.2
Giusti, P.3
-
22
-
-
84874280249
-
ATP release and purinergic signaling in NLRP3 inflammasome activation
-
A. Gombault, L. Baron, and I. Couillin ATP release and purinergic signaling in NLRP3 inflammasome activation Front Immunol 3 2012 414
-
(2012)
Front Immunol
, vol.3
, pp. 414
-
-
Gombault, A.1
Baron, L.2
Couillin, I.3
-
23
-
-
77951638914
-
Basal release of ATP: An autocrine-paracrine mechanism for cell regulation
-
R. Corriden, and P.A. Insel Basal release of ATP: an autocrine-paracrine mechanism for cell regulation Sci Signal 3 104 2010 re1
-
(2010)
Sci Signal
, vol.3
, Issue.104
, pp. 1
-
-
Corriden, R.1
Insel, P.A.2
-
24
-
-
84874083128
-
The role of purinergic signaling in depressive disorders
-
B. Sperlagh, C. Csolle, R.D. Ando, F. Goloncser, A. Kittel, and M. Baranyi The role of purinergic signaling in depressive disorders Neuropsychopharmacol Hung 14 4 2012 231 238
-
(2012)
Neuropsychopharmacol Hung
, vol.14
, Issue.4
, pp. 231-238
-
-
Sperlagh, B.1
Csolle, C.2
Ando, R.D.3
Goloncser, F.4
Kittel, A.5
Baranyi, M.6
-
25
-
-
0037025282
-
Extracellular ATP and P2X7 receptors in neurodegeneration
-
R. Le Feuvre, D. Brough, and N. Rothwell Extracellular ATP and P2X7 receptors in neurodegeneration Eur J Pharmacol 447 2-3 2002 261 269
-
(2002)
Eur J Pharmacol
, vol.447
, Issue.23
, pp. 261-269
-
-
Le Feuvre, R.1
Brough, D.2
Rothwell, N.3
-
26
-
-
79955114285
-
P2RX7 gene is associated consistently with mood disorders and predicts clinical outcome in three clinical cohorts
-
P. Soronen, O. Mantere, T. Melartin, K. Suominen, M. Vuorilehto, and H. Rytsala et al. P2RX7 gene is associated consistently with mood disorders and predicts clinical outcome in three clinical cohorts Am J Med Genet B Neuropsychiatr Genet 156B 4 2011 435 447
-
(2011)
Am J Med Genet B Neuropsychiatr Genet
, vol.156 B
, Issue.4
, pp. 435-447
-
-
Soronen, P.1
Mantere, O.2
Melartin, T.3
Suominen, K.4
Vuorilehto, M.5
Rytsala, H.6
-
27
-
-
80054862035
-
Cognitive manic symptoms associated with the P2RX7 gene in bipolar disorder
-
L. Backlund, P. Nikamo, D.S. Hukic, I.R. Ek, L. Traskman-Bendz, and M. Landen et al. Cognitive manic symptoms associated with the P2RX7 gene in bipolar disorder Bipolar Disord 13 5-6 2011 500 508
-
(2011)
Bipolar Disord
, vol.13
, Issue.56
, pp. 500-508
-
-
Backlund, L.1
Nikamo, P.2
Hukic, D.S.3
Ek, I.R.4
Traskman-Bendz, L.5
Landen, M.6
-
28
-
-
33745047597
-
Analysis of single nucleotide polymorphisms in genes in the chromosome 12Q24.31 region points to P2RX7 as a susceptibility gene to bipolar affective disorder
-
N. Barden, M. Harvey, B. Gagne, E. Shink, M. Tremblay, and C. Raymond et al. Analysis of single nucleotide polymorphisms in genes in the chromosome 12Q24.31 region points to P2RX7 as a susceptibility gene to bipolar affective disorder Am J Med Genet B Neuropsychiatr Genet 141B 4 2006 374 382
-
(2006)
Am J Med Genet B Neuropsychiatr Genet
, vol.141 B
, Issue.4
, pp. 374-382
-
-
Barden, N.1
Harvey, M.2
Gagne, B.3
Shink, E.4
Tremblay, M.5
Raymond, C.6
-
29
-
-
66249146391
-
Case-control studies show that a non-conservative amino-acid change from a glutamine to arginine in the P2RX7 purinergic receptor protein is associated with both bipolar- and unipolar-affective disorders
-
A. McQuillin, N.J. Bass, K. Choudhury, V. Puri, M. Kosmin, and J. Lawrence et al. Case-control studies show that a non-conservative amino-acid change from a glutamine to arginine in the P2RX7 purinergic receptor protein is associated with both bipolar- and unipolar-affective disorders Mol Psychiatry 14 6 2009 614 620
-
(2009)
Mol Psychiatry
, vol.14
, Issue.6
, pp. 614-620
-
-
McQuillin, A.1
Bass, N.J.2
Choudhury, K.3
Puri, V.4
Kosmin, M.5
Lawrence, J.6
-
30
-
-
77955776526
-
Two haplotypes of the P2X7 receptor containing the Ala-348 to Thr polymorphism exhibit a gain-of-function effect and enhanced interleukin-1{beta} secretion
-
L. Stokes, S.J. Fuller, R. Sluyter, K.K. Skarratt, B.J. Gu, and J.S. Wiley Two haplotypes of the P2X7 receptor containing the Ala-348 to Thr polymorphism exhibit a gain-of-function effect and enhanced interleukin-1{beta} secretion FASEB J 24 8 2010 2916 2927
-
(2010)
FASEB J
, vol.24
, Issue.8
, pp. 2916-2927
-
-
Stokes, L.1
Fuller, S.J.2
Sluyter, R.3
Skarratt, K.K.4
Gu, B.J.5
Wiley, J.S.6
-
31
-
-
77950941000
-
Single nucleotide polymorphisms that were identified in affective mood disorders affect ATP-activated P2X7 receptor functions
-
S. Roger, Z.-Z. Mei, J.M. Baldwin, L. Dong, H. Bradley, and S.A. Baldwin et al. Single nucleotide polymorphisms that were identified in affective mood disorders affect ATP-activated P2X7 receptor functions J Psychiatr Res 44 6 2010 347 355
-
(2010)
J Psychiatr Res
, vol.44
, Issue.6
, pp. 347-355
-
-
Roger, S.1
Mei, Z.-Z.2
Baldwin, J.M.3
Dong, L.4
Bradley, H.5
Baldwin, S.A.6
-
32
-
-
72049129677
-
P2RX7: A bipolar and unipolar disorder candidate susceptibility gene?
-
E.K. Green, D. Grozeva, R. Raybould, G. Elvidge, S. Macgregor, and I. Craig et al. P2RX7: a bipolar and unipolar disorder candidate susceptibility gene? Am J Med Genet B Neuropsychiatr Genet 150B 8 2009 1063 1069
-
(2009)
Am J Med Genet B Neuropsychiatr Genet
, vol.150 B
, Issue.8
, pp. 1063-1069
-
-
Green, E.K.1
Grozeva, D.2
Raybould, R.3
Elvidge, G.4
Macgregor, S.5
Craig, I.6
-
33
-
-
70349311857
-
Variation in P2RX7 candidate gene (rs2230912) is not associated with bipolar i disorder and unipolar major depression in four European samples
-
M. Grigoroiu-Serbanescu, S. Herms, T.W. Muhleisen, A. Georgi, C.C. Diaconu, and J. Strohmaier et al. Variation in P2RX7 candidate gene (rs2230912) is not associated with bipolar I disorder and unipolar major depression in four European samples Am J Med Genet B Neuropsychiatr Genet 150B 7 2009 1017 1021
-
(2009)
Am J Med Genet B Neuropsychiatr Genet
, vol.150 B
, Issue.7
, pp. 1017-1021
-
-
Grigoroiu-Serbanescu, M.1
Herms, S.2
Muhleisen, T.W.3
Georgi, A.4
Diaconu, C.C.5
Strohmaier, J.6
-
34
-
-
79960914211
-
Resilience and reduced c-Fos expression in P2X7 receptor knockout mice exposed to repeated forced swim test
-
A.A. Boucher, J.C. Arnold, G.E. Hunt, A. Spiro, J. Spencer, and C. Brown et al. Resilience and reduced c-Fos expression in P2X7 receptor knockout mice exposed to repeated forced swim test Neuroscience 189 2011 170 177
-
(2011)
Neuroscience
, vol.189
, pp. 170-177
-
-
Boucher, A.A.1
Arnold, J.C.2
Hunt, G.E.3
Spiro, A.4
Spencer, J.5
Brown, C.6
-
35
-
-
58549092549
-
Behavioral profile of P2X7 receptor knockout mice in animal models of depression and anxiety: Relevance for neuropsychiatric disorders
-
A.M. Basso, N.A. Bratcher, R.R. Harris, M.F. Jarvis, M.W. Decker, and L.E. Rueter Behavioral profile of P2X7 receptor knockout mice in animal models of depression and anxiety: relevance for neuropsychiatric disorders Behav Brain Res 198 1 2009 83 90
-
(2009)
Behav Brain Res
, vol.198
, Issue.1
, pp. 83-90
-
-
Basso, A.M.1
Bratcher, N.A.2
Harris, R.R.3
Jarvis, M.F.4
Decker, M.W.5
Rueter, L.E.6
-
36
-
-
84871528843
-
The absence of P2X7 receptors (P2rx7) on non-haematopoietic cells leads to selective alteration in mood-related behaviour with dysregulated gene expression and stress reactivity in mice
-
C. Csölle, R.D. Ando, A. Kittel, F. Gölöncsér, M. Baranyi, and K. Soproni et al. The absence of P2X7 receptors (P2rx7) on non-haematopoietic cells leads to selective alteration in mood-related behaviour with dysregulated gene expression and stress reactivity in mice Int J Neuropsychopharmacol 16 1 2013 213 233
-
(2013)
Int J Neuropsychopharmacol
, vol.16
, Issue.1
, pp. 213-233
-
-
Csölle, C.1
Ando, R.D.2
Kittel, A.3
Gölöncsér, F.4
Baranyi, M.5
Soproni, K.6
-
37
-
-
84879260455
-
Neurochemical changes in the mouse hippocampus underlying the antidepressant effect of genetic deletion of P2X7 receptors
-
C. Csölle, M. Baranyi, G. Zsilla, A. Kittel, F. Gölö ncsér, and P. Illes Neurochemical changes in the mouse hippocampus underlying the antidepressant effect of genetic deletion of P2X7 receptors PLoS One 8 6 2013 e66547
-
(2013)
PLoS One
, vol.8
, Issue.6
, pp. 66547
-
-
Csölle, C.1
Baranyi, M.2
Zsilla, G.3
Kittel, A.4
Gölöncsér, F.5
Illes, P.6
-
38
-
-
38649092266
-
IL-1beta is an essential mediator of the antineurogenic and anhedonic effects of stress
-
J.W. Koo, and R.S. Duman IL-1beta is an essential mediator of the antineurogenic and anhedonic effects of stress Proc Natl Acad Sci USA 105 2 2008 751 756
-
(2008)
Proc Natl Acad Sci USA
, vol.105
, Issue.2
, pp. 751-756
-
-
Koo, J.W.1
Duman, R.S.2
-
39
-
-
68149110223
-
Evidence for IL-1 receptor blockade as a therapeutic strategy for the treatment of depression
-
J.W. Koo, and R.S. Duman Evidence for IL-1 receptor blockade as a therapeutic strategy for the treatment of depression Curr Opin Investig Drugs 10 7 2009 664 671
-
(2009)
Curr Opin Investig Drugs
, vol.10
, Issue.7
, pp. 664-671
-
-
Koo, J.W.1
Duman, R.S.2
-
40
-
-
64749112450
-
Interleukin-1 receptor null mutant mice show decreased anxiety-like behavior and enhanced fear memory
-
J.W. Koo, and R.S. Duman Interleukin-1 receptor null mutant mice show decreased anxiety-like behavior and enhanced fear memory Neurosci Lett 456 1 2009 39 43
-
(2009)
Neurosci Lett
, vol.456
, Issue.1
, pp. 39-43
-
-
Koo, J.W.1
Duman, R.S.2
-
41
-
-
45549084470
-
Brain interleukin-1 mediates chronic stress-induced depression in mice via adrenocortical activation and hippocampal neurogenesis suppression
-
I. Goshen, T. Kreisel, O. Ben-Menachem-Zidon, T. Licht, J. Weidenfeld, and T. Ben-Hur et al. Brain interleukin-1 mediates chronic stress-induced depression in mice via adrenocortical activation and hippocampal neurogenesis suppression Mol Psychiatry 13 7 2008 717 728
-
(2008)
Mol Psychiatry
, vol.13
, Issue.7
, pp. 717-728
-
-
Goshen, I.1
Kreisel, T.2
Ben-Menachem-Zidon, O.3
Licht, T.4
Weidenfeld, J.5
Ben-Hur, T.6
-
42
-
-
84873279865
-
The role of the innate immune system in psychiatric disorders
-
K.A. Jones, and C. Thomsen The role of the innate immune system in psychiatric disorders Mol Cell Neurosci 53 2013 52 62
-
(2013)
Mol Cell Neurosci
, vol.53
, pp. 52-62
-
-
Jones, K.A.1
Thomsen, C.2
-
43
-
-
77950022786
-
Increased excitotoxicity and neuroinflammatory markers in postmortem frontal cortex from bipolar disorder patients
-
J.S. Rao, G.J. Harry, S.I. Rapoport, and H.W. Kim Increased excitotoxicity and neuroinflammatory markers in postmortem frontal cortex from bipolar disorder patients Mol Psychiatry 15 4 2010 384 392
-
(2010)
Mol Psychiatry
, vol.15
, Issue.4
, pp. 384-392
-
-
Rao, J.S.1
Harry, G.J.2
Rapoport, S.I.3
Kim, H.W.4
-
44
-
-
79953100305
-
Elevation of cerebrospinal fluid interleukin-1ss in bipolar disorder
-
J. Soderlund, S.K. Olsson, M. Samuelsson, L. Walther-Jallow, C. Johansson, and S. Erhardt et al. Elevation of cerebrospinal fluid interleukin-1ss in bipolar disorder J Psychiatry Neurosci 36 2 2011 114 118
-
(2011)
J Psychiatry Neurosci
, vol.36
, Issue.2
, pp. 114-118
-
-
Soderlund, J.1
Olsson, S.K.2
Samuelsson, M.3
Walther-Jallow, L.4
Johansson, C.5
Erhardt, S.6
-
45
-
-
84861844945
-
In vivo P2X7 inhibition reduces amyloid plaques in Alzheimer's disease through GSK3beta and secretases
-
J.I. Diaz-Hernandez, R. Gomez-Villafuertes, M. Leon-Otegui, L. Hontecillas-Prieto, A. Del Puerto, and J.L. Trejo et al. In vivo P2X7 inhibition reduces amyloid plaques in Alzheimer's disease through GSK3beta and secretases Neurobiol Aging 33 8 2012 1816 1828
-
(2012)
Neurobiol Aging
, vol.33
, Issue.8
, pp. 1816-1828
-
-
Diaz-Hernandez, J.I.1
Gomez-Villafuertes, R.2
Leon-Otegui, M.3
Hontecillas-Prieto, L.4
Del Puerto, A.5
Trejo, J.L.6
-
46
-
-
84877061566
-
Silencing of the P2X7 receptor enhances amyloid-beta phagocytosis by microglia
-
J. Ni, P. Wang, J. Zhang, W. Chen, and L. Gu Silencing of the P2X7 receptor enhances amyloid-beta phagocytosis by microglia Biochem Biophys Res Commun 434 2 2013 363 369
-
(2013)
Biochem Biophys Res Commun
, vol.434
, Issue.2
, pp. 363-369
-
-
Ni, J.1
Wang, P.2
Zhang, J.3
Chen, W.4
Gu, L.5
-
47
-
-
78951488216
-
The purinergic receptor P2X7 triggers alpha-secretase-dependent processing of the amyloid precursor protein
-
C. Delarasse, R. Auger, P. Gonnord, B. Fontaine, and J.M. Kanellopoulos The purinergic receptor P2X7 triggers alpha-secretase-dependent processing of the amyloid precursor protein J Biol Chem 286 4 2011 2596 2606
-
(2011)
J Biol Chem
, vol.286
, Issue.4
, pp. 2596-2606
-
-
Delarasse, C.1
Auger, R.2
Gonnord, P.3
Fontaine, B.4
Kanellopoulos, J.M.5
-
48
-
-
80054005767
-
Gain-of-function of P2X7 receptor gene variants in multiple sclerosis
-
O. Oyanguren-Desez, A. Rodriguez-Antiguedad, P. Villoslada, M. Domercq, E. Alberdi, and C. Matute Gain-of-function of P2X7 receptor gene variants in multiple sclerosis Cell Calcium 50 5 2011 468 472
-
(2011)
Cell Calcium
, vol.50
, Issue.5
, pp. 468-472
-
-
Oyanguren-Desez, O.1
Rodriguez-Antiguedad, A.2
Villoslada, P.3
Domercq, M.4
Alberdi, E.5
Matute, C.6
-
49
-
-
84860905529
-
Seizure suppression and neuroprotection by targeting the purinergic P2X7 receptor during status epilepticus in mice
-
T. Engel, R. Gomez-Villafuertes, K. Tanaka, G. Mesuret, A. Sanz-Rodriguez, and P. Garcia-Huerta et al. Seizure suppression and neuroprotection by targeting the purinergic P2X7 receptor during status epilepticus in mice FASEB J 26 4 2012 1616 1628
-
(2012)
FASEB J
, vol.26
, Issue.4
, pp. 1616-1628
-
-
Engel, T.1
Gomez-Villafuertes, R.2
Tanaka, K.3
Mesuret, G.4
Sanz-Rodriguez, A.5
Garcia-Huerta, P.6
-
50
-
-
67649383228
-
Altered P2X7-receptor level and function in mouse models of Huntington's disease and therapeutic efficacy of antagonist administration
-
M. Diaz-Hernandez, M. Diez-Zaera, J. Sanchez-Nogueiro, R. Gomez-Villafuertes, J.M. Canals, and J. Alberch et al. Altered P2X7-receptor level and function in mouse models of Huntington's disease and therapeutic efficacy of antagonist administration FASEB J 23 6 2009 1893 1906
-
(2009)
FASEB J
, vol.23
, Issue.6
, pp. 1893-1906
-
-
Diaz-Hernandez, M.1
Diez-Zaera, M.2
Sanchez-Nogueiro, J.3
Gomez-Villafuertes, R.4
Canals, J.M.5
Alberch, J.6
-
51
-
-
0038143359
-
P2X7 mediates superoxide production in primary microglia and is up-regulated in a transgenic mouse model of Alzheimer's disease
-
L.K. Parvathenani, S. Tertyshnikova, C.R. Greco, S.B. Roberts, B. Robertson, and R. Posmantur P2X7 mediates superoxide production in primary microglia and is up-regulated in a transgenic mouse model of Alzheimer's disease J Biol Chem 278 15 2003 13309 13317
-
(2003)
J Biol Chem
, vol.278
, Issue.15
, pp. 13309-13317
-
-
Parvathenani, L.K.1
Tertyshnikova, S.2
Greco, C.R.3
Roberts, S.B.4
Robertson, B.5
Posmantur, R.6
-
52
-
-
1642493590
-
P2X7 receptor modulation of beta-amyloid- and LPS-induced cytokine secretion from human macrophages and microglia
-
D. Rampe, L. Wang, and G.E. Ringheim P2X7 receptor modulation of beta-amyloid- and LPS-induced cytokine secretion from human macrophages and microglia J Neuroimmunol 147 1-2 2004 56 61
-
(2004)
J Neuroimmunol
, vol.147
, Issue.12
, pp. 56-61
-
-
Rampe, D.1
Wang, L.2
Ringheim, G.E.3
-
53
-
-
64249169414
-
Activation of microglia by amyloid beta requires P2X7 receptor expression
-
J.M. Sanz, P. Chiozzi, D. Ferrari, M. Colaianna, M. Idzko, and S. Falzoni et al. Activation of microglia by amyloid beta requires P2X7 receptor expression J Immunol 182 7 2009 4378 4385
-
(2009)
J Immunol
, vol.182
, Issue.7
, pp. 4378-4385
-
-
Sanz, J.M.1
Chiozzi, P.2
Ferrari, D.3
Colaianna, M.4
Idzko, M.5
Falzoni, S.6
-
54
-
-
33750601018
-
Upregulated expression of purinergic P2X(7) receptor in Alzheimer disease and amyloid-beta peptide-treated microglia and in peptide-injected rat hippocampus
-
J.G. McLarnon, J.K. Ryu, D.G. Walker, and H.B. Choi Upregulated expression of purinergic P2X(7) receptor in Alzheimer disease and amyloid-beta peptide-treated microglia and in peptide-injected rat hippocampus J Neuropathol Exp Neurol 65 11 2006 1090 1097
-
(2006)
J Neuropathol Exp Neurol
, vol.65
, Issue.11
, pp. 1090-1097
-
-
McLarnon, J.G.1
Ryu, J.K.2
Walker, D.G.3
Choi, H.B.4
-
56
-
-
84860157822
-
Imaging microglial/macrophage activation in spinal cords of experimental autoimmune encephalomyelitis rats by positron emission tomography using the mitochondrial 18 kDa translocator protein radioligand [(1)(8)F]DPA-714
-
G. Abourbeh, B. Theze, R. Maroy, A. Dubois, V. Brulon, and Y. Fontyn et al. Imaging microglial/macrophage activation in spinal cords of experimental autoimmune encephalomyelitis rats by positron emission tomography using the mitochondrial 18 kDa translocator protein radioligand [(1)(8)F]DPA-714 J Neurosci 32 17 2012 5728 5736
-
(2012)
J Neurosci
, vol.32
, Issue.17
, pp. 5728-5736
-
-
Abourbeh, G.1
Theze, B.2
Maroy, R.3
Dubois, A.4
Brulon, V.5
Fontyn, Y.6
-
57
-
-
50249159536
-
P2x7 deficiency suppresses development of experimental autoimmune encephalomyelitis
-
A.J. Sharp, P.E. Polak, V. Simonini, S.X. Lin, J.C. Richardson, and E.R. Bongarzone et al. P2x7 deficiency suppresses development of experimental autoimmune encephalomyelitis J Neuroinflammation 5 1 2008 33
-
(2008)
J Neuroinflammation
, vol.5
, Issue.1
, pp. 33
-
-
Sharp, A.J.1
Polak, P.E.2
Simonini, V.3
Lin, S.X.4
Richardson, J.C.5
Bongarzone, E.R.6
-
58
-
-
34347333404
-
Discovery of P2X7 receptor-selective antagonists offers new insights into P2X7 receptor function and indicates a role in chronic pain states
-
D.L. Donnelly-Roberts, and M.F. Jarvis Discovery of P2X7 receptor-selective antagonists offers new insights into P2X7 receptor function and indicates a role in chronic pain states Br J Pharmacol 151 5 2007 571 579
-
(2007)
Br J Pharmacol
, vol.151
, Issue.5
, pp. 571-579
-
-
Donnelly-Roberts, D.L.1
Jarvis, M.F.2
-
59
-
-
20144375454
-
Disruption of the P2X7 purinoceptor gene abolishes chronic inflammatory and neuropathic pain
-
I.P. Chessell, J.P. Hatcher, C. Bountra, A.D. Michel, J.P. Hughes, and P. Green et al. Disruption of the P2X7 purinoceptor gene abolishes chronic inflammatory and neuropathic pain Pain 114 3 2005 386 396
-
(2005)
Pain
, vol.114
, Issue.3
, pp. 386-396
-
-
Chessell, I.P.1
Hatcher, J.P.2
Bountra, C.3
Michel, A.D.4
Hughes, J.P.5
Green, P.6
-
60
-
-
0037096207
-
Absence of the P2X7 receptor alters leukocyte function and attenuates an inflammatory response
-
J.M. Labasi, N. Petrushova, C. Donovan, S. McCurdy, P. Lira, and M.M. Payette et al. Absence of the P2X7 receptor alters leukocyte function and attenuates an inflammatory response J Immunol 168 12 2002 6436 6445
-
(2002)
J Immunol
, vol.168
, Issue.12
, pp. 6436-6445
-
-
Labasi, J.M.1
Petrushova, N.2
Donovan, C.3
McCurdy, S.4
Lira, P.5
Payette, M.M.6
-
61
-
-
30744450479
-
Interleukin-1alphabeta gene-deficient mice show reduced nociceptive sensitivity in models of inflammatory and neuropathic pain but not post-operative pain
-
P. Honore, C.L. Wade, C. Zhong, R.R. Harris, C. Wu, and T. Ghayur et al. Interleukin-1alphabeta gene-deficient mice show reduced nociceptive sensitivity in models of inflammatory and neuropathic pain but not post-operative pain Behav Brain Res 167 2 2006 355 364
-
(2006)
Behav Brain Res
, vol.167
, Issue.2
, pp. 355-364
-
-
Honore, P.1
Wade, C.L.2
Zhong, C.3
Harris, R.R.4
Wu, C.5
Ghayur, T.6
-
62
-
-
77955653157
-
Discovery and structure-activity relationships of a series of pyroglutamic acid amide antagonists of the P2X7 receptor
-
M.H. Abdi, P.J. Beswick, A. Billinton, L.J. Chambers, A. Charlton, and S.D. Collins et al. Discovery and structure-activity relationships of a series of pyroglutamic acid amide antagonists of the P2X7 receptor Bioorg Med Chem Lett 20 2010 5080 5084
-
(2010)
Bioorg Med Chem Lett
, vol.20
, pp. 5080-5084
-
-
Abdi, M.H.1
Beswick, P.J.2
Billinton, A.3
Chambers, L.J.4
Charlton, A.5
Collins, S.D.6
-
63
-
-
77952105608
-
Synthesis and structure-activity relationships of a series of (1H-pyrazol-4-yl)acetamide antagonists of the P2X7 receptor
-
L.J. Chambers, A.J. Stevens, A.P. Moses, A.D. Michel, D.S. Walter, and D.J. Davies et al. Synthesis and structure-activity relationships of a series of (1H-pyrazol-4-yl)acetamide antagonists of the P2X7 receptor Bioorg Med Chem Lett 20 2010 3161 3164
-
(2010)
Bioorg Med Chem Lett
, vol.20
, pp. 3161-3164
-
-
Chambers, L.J.1
Stevens, A.J.2
Moses, A.P.3
Michel, A.D.4
Walter, D.S.5
Davies, D.J.6
-
64
-
-
77958031377
-
Identification of 2-oxo-N-(phenylmethyl)-4-imidazolidinecarboxamide antagonists of the P2X(7) receptor
-
L. Abberley, A. Bebius, P.J. Beswick, A. Billinton, K.L. Collis, and D.K. Dean et al. Identification of 2-oxo-N-(phenylmethyl)-4-imidazolidinecarboxamide antagonists of the P2X(7) receptor Bioorg Med Chem Lett 20 22 2010 6370 6374
-
(2010)
Bioorg Med Chem Lett
, vol.20
, Issue.22
, pp. 6370-6374
-
-
Abberley, L.1
Bebius, A.2
Beswick, P.J.3
Billinton, A.4
Collis, K.L.5
Dean, D.K.6
-
65
-
-
84871151589
-
Pharmacokinetic and phamacodynamic profiling of a P2X7 receptor allosteric modulator GSK1482160 in healthy human subjects
-
Z. Ali, B. Laurijssens, T. Ostenfeld, S. McHugh, A. Stylianou, and P. Scott-Stevens et al. Pharmacokinetic and phamacodynamic profiling of a P2X7 receptor allosteric modulator GSK1482160 in healthy human subjects Br J Clin Phamacol 75 2012 197 207
-
(2012)
Br J Clin Phamacol
, vol.75
, pp. 197-207
-
-
Ali, Z.1
Laurijssens, B.2
Ostenfeld, T.3
McHugh, S.4
Stylianou, A.5
Scott-Stevens, P.6
-
66
-
-
84859456520
-
Efficacy and safety of CE-224,535, an antagonist of P2X7 Receptor, in treatment of patients with rheumatoid arthritis inadequately controlled by methotrexate
-
T.C. Stock, B.J. Bloom, N. Wei, S. Ishaq, W. Park, and X. Wang et al. Efficacy and safety of CE-224,535, an antagonist of P2X7 Receptor, in treatment of patients with rheumatoid arthritis inadequately controlled by methotrexate J Rheumatol 39 4 2012 720 727
-
(2012)
J Rheumatol
, vol.39
, Issue.4
, pp. 720-727
-
-
Stock, T.C.1
Bloom, B.J.2
Wei, N.3
Ishaq, S.4
Park, W.5
Wang, X.6
-
67
-
-
84866105881
-
Clinical evaluation of the efficacy of the P2X7 purinergic receptor antagonist AZD9056 on the signs and symptoms of rheumatoid arthritis in patients with active disease despite treatment with methotrexate or sulphasalazine
-
E.C. Keystone, M.M. Wang, M. Layton, S. Hollis, and I.B. McInnes Clinical evaluation of the efficacy of the P2X7 purinergic receptor antagonist AZD9056 on the signs and symptoms of rheumatoid arthritis in patients with active disease despite treatment with methotrexate or sulphasalazine Ann Rheum Dis 71 2012 1630 1635
-
(2012)
Ann Rheum Dis
, vol.71
, pp. 1630-1635
-
-
Keystone, E.C.1
Wang, M.M.2
Layton, M.3
Hollis, S.4
McInnes, I.B.5
-
68
-
-
84858159803
-
Purinergic systems, neuropathic pain and the role of microglia
-
K. Inoue, and M. Tsuda Purinergic systems, neuropathic pain and the role of microglia Exp Neurol 234 2 2012 293 301
-
(2012)
Exp Neurol
, vol.234
, Issue.2
, pp. 293-301
-
-
Inoue, K.1
Tsuda, M.2
-
69
-
-
74949123761
-
P2X7-dependent release of interleukin-1beta and nociception in the spinal cord following lipopolysaccharide
-
A.K. Clark, A.A. Staniland, F. Marchand, T.K. Kaan, S.B. McMahon, and M. Malcangio P2X7-dependent release of interleukin-1beta and nociception in the spinal cord following lipopolysaccharide J Neurosci 30 2 2010 573 582
-
(2010)
J Neurosci
, vol.30
, Issue.2
, pp. 573-582
-
-
Clark, A.K.1
Staniland, A.A.2
Marchand, F.3
Kaan, T.K.4
McMahon, S.B.5
Malcangio, M.6
-
70
-
-
81255152299
-
Synthesis and SAR development of novel P2X7 receptor antagonists for the treatment of pain: Part 2
-
S. Brumfield, J.J. Matasi, D. Tulshian, M. Czarniecki, W. Greenlee, and C. Garlisi et al. Synthesis and SAR development of novel P2X7 receptor antagonists for the treatment of pain: part 2 Bioorg Med Chem Lett 21 24 2011 7287 7290
-
(2011)
Bioorg Med Chem Lett
, vol.21
, Issue.24
, pp. 7287-7290
-
-
Brumfield, S.1
Matasi, J.J.2
Tulshian, D.3
Czarniecki, M.4
Greenlee, W.5
Garlisi, C.6
-
71
-
-
79957836035
-
Synthesis and SAR development of novel P2X7 receptor antagonists for the treatment of pain: Part 1
-
J.J. Matasi, S. Brumfield, D. Tulshian, M. Czarnecki, W. Greenlee, and C.G. Garlisi et al. Synthesis and SAR development of novel P2X7 receptor antagonists for the treatment of pain: part 1 Bioorg Med Chem Lett 21 12 2011 3805 3808
-
(2011)
Bioorg Med Chem Lett
, vol.21
, Issue.12
, pp. 3805-3808
-
-
Matasi, J.J.1
Brumfield, S.2
Tulshian, D.3
Czarnecki, M.4
Greenlee, W.5
Garlisi, C.G.6
-
73
-
-
66249140600
-
-
inventors; Glaxo Group Limited, assignee Patent WO 2008003697A1
-
Chambers LJ, Gleave R, Senger S, Walter DS, inventors; Glaxo Group Limited, assignee. Preparation of N-(phenylmethyl)-5-oxoprolinamides derivatives as P2X7 antagonists for the treatment of pain, inflammation and neurodegeneration. Patent WO 2008003697A1; 2008.
-
(2008)
Preparation of N-(phenylmethyl)-5-oxoprolinamides Derivatives As P2X7 Antagonists for the Treatment of Pain, Inflammation and Neurodegeneration
-
-
Chambers, L.J.1
Gleave, R.2
Senger, S.3
Walter, D.S.4
-
74
-
-
77955414233
-
Structure-activity relationships and in vivo activity of (1H-pyrazol-4-yl)acetamide antagonists of the P2X7 receptor
-
P.J. Beswick, A. Billinton, L.J. Chambers, D.K. Dean, E. Fonfria, and R.J. Gleave et al. Structure-activity relationships and in vivo activity of (1H-pyrazol-4-yl)acetamide antagonists of the P2X7 receptor Bioorg Med Chem Lett 20 2010 4653 4656
-
(2010)
Bioorg Med Chem Lett
, vol.20
, pp. 4653-4656
-
-
Beswick, P.J.1
Billinton, A.2
Chambers, L.J.3
Dean, D.K.4
Fonfria, E.5
Gleave, R.J.6
-
75
-
-
1542619335
-
Glu496 to Ala polymorphism in the P2X7 receptor impairs ATP-induced IL1b release from human monocytes
-
R. Sluyter, A. Shemon, and J. Wiley Glu496 to Ala polymorphism in the P2X7 receptor impairs ATP-induced IL1b release from human monocytes J Immunol 172 2004 3399 3405
-
(2004)
J Immunol
, vol.172
, pp. 3399-3405
-
-
Sluyter, R.1
Shemon, A.2
Wiley, J.3
-
76
-
-
84892418509
-
-
T. Stock, B.J. Bloom, X. Wang, P. Gupta, and C. Mebus European League Against Rheumatism, Rome, Italy, June 16-19 2010
-
(2010)
European League Against Rheumatism, Rome, Italy, June 16-19
-
-
Stock, T.1
Bloom, B.J.2
Wang, X.3
Gupta, P.4
Mebus, C.5
-
77
-
-
79957813413
-
Optimization of the physicochemical and pharmacokinetic attributes in a 6-azauracil series of P2X7 receptor antagonists leading to the discovery of the clinical candidate CE-224,535
-
A.J. Duplantier, M.A. Dombroski, C. Subramanyam, A.M. Beaulieu, S.-P. Chang, and C.A. Gabel Optimization of the physicochemical and pharmacokinetic attributes in a 6-azauracil series of P2X7 receptor antagonists leading to the discovery of the clinical candidate CE-224,535 Bioorg Med Chem Lett 21 2011 3708 3711
-
(2011)
Bioorg Med Chem Lett
, vol.21
, pp. 3708-3711
-
-
Duplantier, A.J.1
Dombroski, M.A.2
Subramanyam, C.3
Beaulieu, A.M.4
Chang, S.-P.5
Gabel, C.A.6
-
78
-
-
84892389316
-
-
Evotec. Evotec development partnerships
-
Evotec. Evotec development partnerships, http://evotec.com/article/en/ Alliances-Projects/EVT401-P2X7-Antagonist/67/4?selected-category-id=6.
-
-
-
-
80
-
-
66249138835
-
Antagonists of the P2X(7) receptor. from lead identification to drug development
-
S.D. Guile, L. Alcaraz, T.N. Birkinshaw, K.C. Bowers, M.R. Ebden, and M. Furber et al. Antagonists of the P2X(7) receptor. From lead identification to drug development J Med Chem 52 10 2009 3123 3141
-
(2009)
J Med Chem
, vol.52
, Issue.10
, pp. 3123-3141
-
-
Guile, S.D.1
Alcaraz, L.2
Birkinshaw, T.N.3
Bowers, K.C.4
Ebden, M.R.5
Furber, M.6
-
82
-
-
66249143399
-
-
inventors; Glaxo Group Limited, assignee Patent WO 2007141267A1
-
Beswick PJ, Chambers LJ, Davies DJ, Dean DK, Demont EM, Roomans S, et al., inventors; Glaxo Group Limited, assignee. N-(phenylmethyl)-2-(1H-pyrazol-4- yl) Acetamide derivatives as P2X7 antagonists for the treatment of pain, inflammation and neurodegeneration. Patent WO 2007141267A1; 2007.
-
(2007)
N-(phenylmethyl)-2-(1H-pyrazol-4-yl) Acetamide Derivatives As P2X7 Antagonists for the Treatment of Pain, Inflammation and Neurodegeneration
-
-
Beswick, P.J.1
Chambers, L.J.2
Davies, D.J.3
Dean, D.K.4
Demont, E.M.5
Et Al., R.S.6
-
83
-
-
34447548576
-
Ligand efficiency indices for effective drug discovery
-
C. Abad-Zapatero Ligand efficiency indices for effective drug discovery Expert Opin Drug Discov 2 4 2007 469 488
-
(2007)
Expert Opin Drug Discov
, vol.2
, Issue.4
, pp. 469-488
-
-
Abad-Zapatero, C.1
-
84
-
-
77955420249
-
Synthesis and biological activity of a series of tetrasubstituted- imidazoles as P2X7 antagonists
-
R.J. Gleave, D.S. Walter, P.J. Beswick, E. Fonfria, A.D. Michel, and S.A. Roman et al. Synthesis and biological activity of a series of tetrasubstituted-imidazoles as P2X7 antagonists Bioorg Med Chem Lett 20 2010 4951 4954
-
(2010)
Bioorg Med Chem Lett
, vol.20
, pp. 4951-4954
-
-
Gleave, R.J.1
Walter, D.S.2
Beswick, P.J.3
Fonfria, E.4
Michel, A.D.5
Roman, S.A.6
-
85
-
-
84892380549
-
-
inventors; Glaxo Group Limited, assignee US patent 20080009541A1
-
Chambers L, Gleave R, Senger S, Walter DS, inventors; Glaxo Group Limited, assignee. Novel receptor antagonists and their methods of use. US patent 20080009541A1; 2009.
-
(2009)
Novel Receptor Antagonists and Their Methods of Use
-
-
Chambers, L.1
Gleave, R.2
Senger, S.3
Walter, D.S.4
-
86
-
-
77951594095
-
-
inventor; Glaxo Group Limited, assignee Patent WO 2009077362A1
-
Walter DS, inventor; Glaxo Group Limited, assignee. Isothiazolidine 1,1-dioxide and tetrahydro-2H-1,2-thiazine 1,1-dioxide derivatives as P2X7 modulators. Patent WO 2009077362A1; 2009.
-
(2009)
Isothiazolidine 1,1-dioxide and tetrahydro-2H-1,2-thiazine 1,1-dioxide Derivatives As P2X7 Modulators
-
-
Walter, D.S.1
-
89
-
-
84866660923
-
-
inventors; Glaxo Group Limited assignee Patent WO 2009053459A1
-
Chambers LJ, Collis KL, Dean DK, Munoz-Muriedas J, Steadman JGA, inventors; Glaxo Group Limited, assignee. 4-Benzoyl-1-substituted-piperazine-2- one derivatives as P2X7 modulators. Patent WO 2009053459A1; 2009.
-
(2009)
4-Benzoyl-1-substituted-piperazine-2-one Derivatives As P2X7 Modulators
-
-
Chambers, L.J.1
Collis, K.L.2
Dean, D.K.3
Munoz-Muriedas, J.4
Steadman, J.G.A.5
-
90
-
-
84892394373
-
-
inventors; Glaxo Group Limited, assignee Patent WO 2010125103A1
-
Chambers LJ, Dean DK, Munoz-Muriedas J, Steadman JGA, Walter DS, inventors; Glaxo Group Limited, assignee. Diketopiperazine derivatives as P2X7 modulators. Patent WO 2010125103A1; 2010.
-
(2010)
Diketopiperazine Derivatives As P2X7 Modulators
-
-
Chambers, L.J.1
Dean, D.K.2
Munoz-Muriedas, J.3
Steadman, J.G.A.4
Walter, D.S.5
-
91
-
-
84892415181
-
-
inventors; Roche Palo Alto LLC, assignee US patent 20100160389A1
-
Berger J, Caroon JM, Lopez-Tapia FJ, Nitzan D, Walker KAM, Zhao S-H, inventors; Roche Palo Alto LLC, assignee. Dihydropyridone amides as P2X7 modulators. US patent 20100160389A1; 2010.
-
(2010)
Dihydropyridone Amides As P2X7 Modulators
-
-
Berger, J.1
Caroon, J.M.2
Lopez-Tapia, F.J.3
Nitzan, D.4
Kam, W.5
Zhao, S.-H.6
-
92
-
-
84892415181
-
-
inventors; Roche Palo Alto LLC, assignee US patent 20100160384A1
-
Berger J, Brotherton-Pleiss CE, Lopez-Tapia FJ, Walker KAM, Zhao S-H, inventors; Roche Palo Alto LLC, assignee. Dihydropyridone amides as P2X7 modulators. US patent 20100160384A1; 2010.
-
(2010)
Dihydropyridone Amides As P2X7 Modulators
-
-
Berger, J.1
Brotherton-Pleiss, C.E.2
Lopez-Tapia, F.J.3
Walker, K.A.M.4
Zhao, S.-H.5
-
93
-
-
84892415181
-
-
inventors; Roche Palo Alto LLC, assignee US patent 20100160373A1
-
Berger J, Caroon JM, Krauss NE, Walker KAM, Zhao S-H, Lopez-Tapia FJ, inventors; Roche Palo Alto LLC, assignee. Dihydropyridone amides as P2X7 modulators. US patent 20100160373A1; 2010.
-
(2010)
Dihydropyridone Amides As P2X7 Modulators
-
-
Berger, J.1
Caroon, J.M.2
Krauss, N.E.3
Walker, K.A.M.4
Zhao, S.-H.5
Lopez-Tapia, F.J.6
-
97
-
-
77952893309
-
Pilot-Plant Preparation of 3,4-Dihydropyridin-2-one derivatives, the core structures of P2X7 receptor antagonists
-
X. Huang, S. Broadbent, C. Dvorak, and S.-H. Zhao Pilot-Plant Preparation of 3,4-Dihydropyridin-2-one derivatives, the core structures of P2X7 receptor antagonists Org Process Res Dev 14 2010 612 616
-
(2010)
Org Process Res Dev
, vol.14
, pp. 612-616
-
-
Huang, X.1
Broadbent, S.2
Dvorak, C.3
Zhao, S.-H.4
-
98
-
-
77951563621
-
-
Shigeta Y, Hirokawa Y, Nagai H, Nagae K, Watanabe T, Io M, et al. inventors; Nissan Chemical Industries Ltd., assignee Patent WO 2009057827A1
-
Shigeta Y, Hirokawa Y, Nagai H, Nagae K, Watanabe T, Io M, et al., inventors; Nissan Chemical Industries Ltd., assignee. Pyridazinone derivatives as P2X7 receptor inhibitors and their preparation, pharmaceutical compositions and use in the treatment of rheumatoid arthritis. Patent WO 2009057827A1; 2009.
-
(2009)
Pyridazinone Derivatives As P2X7 Receptor Inhibitors and Their Preparation, Pharmaceutical Compositions and Use in the Treatment of Rheumatoid Arthritis
-
-
-
100
-
-
84892417878
-
-
inventors; Actelion Pharmaceuticals Ltd., assignee Patent WO 2012114268A1
-
Hilpert K, Hubler F, Murphy M, Renneberg D, inventors; Actelion Pharmaceuticals Ltd., assignee. Benzamide derivatives as P2X7 preceptor antagonists. Patent WO 2012114268A1; 2012.
-
(2012)
Benzamide Derivatives As P2X7 Preceptor Antagonists
-
-
Hilpert, K.1
Hubler, F.2
Murphy, M.3
Renneberg, D.4
-
101
-
-
84892411979
-
-
inventors; Neurogen Corporation, assignee Patent WO 2009012482A2
-
Li H, Yuan J, Bakthavatchalam R, Hodgetts KJ, Capitosti SM, Mao J, et al., inventors; Neurogen Corporation, assignee. Preparation of 5-membered heterocyclic amides and related compounds as specific receptor activity modulators. Patent WO 2009012482A2; 2009.
-
(2009)
Preparation of 5-membered Heterocyclic Amides and Related Compounds As Specific Receptor Activity Modulators
-
-
Li, H.1
Yuan, J.2
Bakthavatchalam, R.3
Hodgetts, K.J.4
Capitosti, S.M.5
Mao, J.6
-
102
-
-
84892422720
-
-
inventor; Affectis Pharmaceuticals AG, assignee Patent WO 2009118175A1
-
7 antagonists and their use. Patent WO 2009118175A1; 2009.
-
(2009)
7 Antagonists and Their Use
-
-
Bos, M.1
-
103
-
-
84892422720
-
-
inventor; Affectis Pharmaceuticals AG, assignee Patent WO 2010118921A1
-
7 antagonists and their use. Patent WO 2010118921A1; 2010.
-
(2010)
7 Antagonists and Their Use
-
-
Bos, M.1
-
104
-
-
84892403465
-
-
inventor; Affectis Pharmaceuticals AG, assignee Patent WO 2011141194A1
-
7 antagonists. Patent WO 2011141194A1; 2011.
-
(2011)
7 Antagonists
-
-
Bos, M.1
-
105
-
-
84892377334
-
-
inventor; Affectis Pharmaceuticals AG, assignee Patent WO 2012163456A1
-
7 antagonists and their use. Patent WO 2012163456A1; 2012.
-
(2012)
7 Antagonists and Their Use
-
-
Boes, M.1
-
106
-
-
84892377334
-
-
inventor; affectis pharmaceuticals ag, assignee Patent WO 2012163792A1
-
7 antagonists and their use. Patent WO 2012163792A1; 2012.
-
(2012)
7 Antagonists and Their Use
-
-
Boes, M.1
-
107
-
-
84892419459
-
-
Affectis Affectis granted patent for AFC-5128, other P2X7 antagonists
-
Affectis. Affectis News and Events. Affectis granted patent for AFC-5128, other P2X7 antagonists http://www.affectis.com/attachments/035- Press%20Release%20Affectis-EP%20patent%20AFC-5128%2020120125.pdf.
-
Affectis News and Events
-
-
-
108
-
-
84855850746
-
-
inventors; Neurogen Corporation, assignee International Patent 2009023623 A1
-
Bakthavatchalam R, Ihle DC, Capitosti SM, Trow DJ, Yuan J, inventors; Neurogen Corporation, assignee, Heteroaryl amide analogues. International Patent 2009023623 A1; 2009.
-
(2009)
Heteroaryl Amide Analogues
-
-
Bakthavatchalam, R.1
Ihle, D.C.2
Capitosti, S.M.3
Trow, D.J.4
Yuan, J.5
-
109
-
-
84855850746
-
-
inventors; H. Lundbeck A/S, assignee Patent WO 2009108551A2
-
Bakthavatchalam R, Ihle DC, Capitosti SM, Trow DJ, Yuan J, inventors; H. Lundbeck A/S, assignee, Heteroaryl amide analogues. Patent WO 2009108551A2; 2009.
-
(2009)
Heteroaryl Amide Analogues
-
-
Bakthavatchalam, R.1
Ihle, D.C.2
Capitosti, S.M.3
Trow, D.J.4
Yuan, J.5
-
115
-
-
66249113481
-
Discovery and biological evaluation of novel cyanoguanidine P2X(7) antagonists with analgesic activity in a rat model of neuropathic pain
-
A. Perez-Medrano, D.L. Donnelly-Roberts, P. Honore, G.C. Hsieh, M.T. Namovic, and S. Peddi et al. Discovery and biological evaluation of novel cyanoguanidine P2X(7) antagonists with analgesic activity in a rat model of neuropathic pain J Med Chem 52 2009 3366 3376
-
(2009)
J Med Chem
, vol.52
, pp. 3366-3376
-
-
Perez-Medrano, A.1
Donnelly-Roberts, D.L.2
Honore, P.3
Hsieh, G.C.4
Namovic, M.T.5
Peddi, S.6
-
116
-
-
58049118595
-
3HA-804598 ([3H]2-cyano-1-[(1S)-1-phenylethyl]-3-quinolin-5-ylguanidine) is a novel, potent, and selective antagonist radioligand for P2X7 receptors
-
D.L. Donnelly-Roberts, M.T. Namovic, B. Surber, S.X. Vaidyanathan, A. Perez-Medrano, and Y. Wang et al. [3H]A-804598 ([3H]2-cyano-1-[(1S)-1- phenylethyl]-3-quinolin-5-ylguanidine) is a novel, potent, and selective antagonist radioligand for P2X7 receptors Neuropharmacology 56 2009 223 229
-
(2009)
Neuropharmacology
, vol.56
, pp. 223-229
-
-
Donnelly-Roberts, D.L.1
Namovic, M.T.2
Surber, B.3
Vaidyanathan, S.X.4
Perez-Medrano, A.5
Wang, Y.6
|